Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in southern province Zambia: A cluster-randomized controlled trial

Journal of Infectious Diseases

Volumn 214, Issue 12, 2016, Pages 1831-1839

  Eisele, Thomas P ^a   Bennett, Adam ^b   Silumbe, Kafula ^d   Finn, Timothy P ^a   Chalwe, Victor ^e   Kamuliwo, Mulakwa ^f   Hamainza, Busiku ^f   Moonga, Hawela ^f   Kooma, Emmanuel ^g   Kawesha, Elizabeth Chizema ^f   Yukich, Joshua ^a   Keating, Joseph ^a   Porter, Travis ^a   Conner, Ruben O ^c   Earle, Duncan ^d   Steketee, Richard W ^c   Miller, John M ^d  

^a TULANE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PATH   (United States)

^d Chainama Hospital College Grounds   (Zambia)

^e University Teaching Hospital   (Zambia)

^f MINISTRY OF HEALTH   (Zambia)

^g Zambia Ministry of Health   (Zambia)

Author keywords

Elimination; Malaria; Mass drug administration

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; OUTCOME ASSESSMENT; PARASITE INCIDENCE; PARASITE PREVALENCE; PARASITE TRANSMISSION; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; ZAMBIA; CHEMOPROPHYLAXIS; DRUG THERAPY; FAMILY SIZE; INCIDENCE; MALARIA, FALCIPARUM; PROCEDURES; TREATMENT OUTCOME;

ANTIMALARIALS; ARTEMISININS; CHEMOPREVENTION; CHILD, PRESCHOOL; DRUG THERAPY; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INCIDENCE; INFANT; MALARIA, FALCIPARUM; MALE; PREVALENCE; QUINOLINES; TREATMENT OUTCOME; ZAMBIA;

EID: 85016049985     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw416     Document Type: Article

References (29)

1. Chizema-Kawesha E, Miller JM, Steketee RW, et al. Scaling up malaria control in Zambia: progress and impact 2005-2008. Am J Trop Med Hyg 2010; 83:480-8.
2. Zambia Ministry of Health. National Malaria Control Programme strategic plan for FY 2011-2015: consolidating malaria gains for impact. Lusaka, Zambia: National Malaria Control Programme, 2011.
3. Tiono AB, Ouedraogo A, Ogutu B, et al. A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Malar J 2013; 12:79.
4. Larsen DA, Bennett A, Silumbe K, et al. Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design. Am J Trop Med Hyg 2015; 92:913-21.
5. Cook J, Xu W, Msellem M, et al. Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar. J Infect Dis 2015; 211:1476-83.
6. Sutcliffe CG, Kobayashi T, Hamapumbu H, et al. Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS One 2012; 7:e31396.
7. Halliday KE, Okello G, Turner EL, et al. Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial. PLoS Med 2014; 11:e1001594.
8. Stresman GH, Baidjoe AY, Stevenson J, et al. Focal screening to identify the subpatent parasite reservoir in an area of low and heterogeneous transmission in the Kenya highlands. J Infect Dis 2015; 212:1768-77.
9. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 2012; 3:1237.
10. McMorrow ML, Aidoo M, Kachur SP. Malaria rapid diagnostic tests in elimination settings-can they find the last parasite? Clin Microbiol Infect 2011; 17:1624-31.
11. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev 2013; 12:CD008846.
12. von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol 2003; 19:452-60.
13. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev 2014; 1:CD010927.
14. Sawa P, Shekalaghe SA, Drakeley CJ, et al. Malaria transmission after artemetherlumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis 2013; 207:1637-45.
15. World Health Organization. Disease surveillance for malaria elimination. Geneva, Switzerland: World Health Organization, 2012.
16. Eisele TP, Silumbe K, Finn T, et al. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial. Trials 2015; 16:347.
17. Zambia Ministry of Health. Guidelines on diagnosis and treatment of malaria in Zambia. 4th ed. Lusaka, Zambia: Zambian Ministry of Health, 2014.
18. Newby G, Hwang J, Koita K, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg 2015; 93:125-34.
19. Song J, Socheat D, Tan B, et al. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J 2010; 9:57.
20. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet 2000; 356:1560-4.
21. Huehne WH. Experience with an insecticide-drug combination and observations on suppressive chloroquine-pyrimethamine treatment. J Trop Med Hyg 1971; 74:110-6.
22. Dapeng L, Leyuan S, Xili L, Xiance Y. A successful control programme for falciparum malaria in Xinyang, China. Trans R Soc Trop Med Hyg 1996; 90:100-2.
23. Gabaldon A, Guerrero L. An attempt to eradicate malaria by the weekly administration of pyrimethamine in areas of out-of-doors transmission in Venezuela. Am J Trop Med Hyg 1959; 8:433-9.
24. Garfield RM, Vermund SH. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet 1983; 2:500-3.
25. Shekalaghe SA, Drakeley C, van den Bosch S, et al. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J 2011; 10:247.
26. von Seidlein L,Walraven G, Milligan PJ, et al. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg 2003; 97:217-25.
27. Gerardin J, Eckhoff P, Wenger EA. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination. BMC Infect Dis 2015; 15:144.
28. Gerardin J, Bever CA, Hamainza B, Miller JM, Eckhoff PA, Wenger EA. Optimal population-level infection detection strategies for malaria control and elimination in a spatial model of malaria transmission. PLoS Comput Biol 2016; 12:e1004707.
29. Keating J, Miller J, Bennett A, Moonga H, Eisele T. Plasmodium falciparum parasite infection prevalence from a household survey in Zambia using microscopy and a rapid diagnostic test: implications for monitoring and evaluation. Acta Trop 2009; 112:277-82.